These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21296997)

  • 1. MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia.
    Vargova K; Curik N; Burda P; Basova P; Kulvait V; Pospisil V; Savvulidi F; Kokavec J; Necas E; Berkova A; Obrtlikova P; Karban J; Mraz M; Pospisilova S; Mayer J; Trneny M; Zavadil J; Stopka T
    Blood; 2011 Apr; 117(14):3816-25. PubMed ID: 21296997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
    Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
    Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells.
    Rozovski U; Calin GA; Setoyama T; D'Abundo L; Harris DM; Li P; Liu Z; Grgurevic S; Ferrajoli A; Faderl S; Burger JA; O'Brien S; Wierda WG; Keating MJ; Estrov Z
    Mol Cancer; 2013 Jun; 12():50. PubMed ID: 23725032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter.
    Chayka O; Kintscher J; Braas D; Klempnauer KH
    Mol Cell Biol; 2005 Jan; 25(1):499-511. PubMed ID: 15601869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-16 Regulates Myeloblastosis Oncogene Expression to Affect Differentiation of Acute Leukemia Cells.
    Yang H; Dai X; Ai Z; Ren R; Gao C; Han J; Ma Y
    Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
    Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
    Leuk Lymphoma; 2015; 56(11):3150-8. PubMed ID: 25860243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
    Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
    BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
    Asslaber D; Piñón JD; Seyfried I; Desch P; Stöcher M; Tinhofer I; Egle A; Merkel O; Greil R
    Blood; 2010 May; 115(21):4191-7. PubMed ID: 20089965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia.
    Li P; Grgurevic S; Liu Z; Harris D; Rozovski U; Calin GA; Keating MJ; Estrov Z
    PLoS One; 2013; 8(6):e64678. PubMed ID: 23750211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
    Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
    Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
    Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
    Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting chronic lymphocytic leukemia microenvironment signals in patients with unmutated disease: microRNA-22 regulates phosphatase and tensin homolog/AKT/FOXO1 pathway in proliferative leukemic cells.
    Palacios F; Prieto D; Abreu C; Ruiz S; Morande P; Fernández-Calero T; Libisch G; Landoni AI; Oppezzo P
    Leuk Lymphoma; 2015 May; 56(5):1560-5. PubMed ID: 25430416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia.
    Ferrer G; Navarro A; Hodgson K; Aymerich M; Pereira A; Baumann T; Monzo M; Moreno C; Montserrat E
    Leuk Lymphoma; 2013 Sep; 54(9):2016-22. PubMed ID: 23286334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells.
    Zauli G; Voltan R; di Iasio MG; Bosco R; Melloni E; Sana ME; Secchiero P
    Clin Cancer Res; 2011 May; 17(9):2712-24. PubMed ID: 21367750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
    Pallasch CP; Patz M; Park YJ; Hagist S; Eggle D; Claus R; Debey-Pascher S; Schulz A; Frenzel LP; Claasen J; Kutsch N; Krause G; Mayr C; Rosenwald A; Plass C; Schultze JL; Hallek M; Wendtner CM
    Blood; 2009 Oct; 114(15):3255-64. PubMed ID: 19692702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-15 and miR-16 induce apoptosis by targeting BCL2.
    Cimmino A; Calin GA; Fabbri M; Iorio MV; Ferracin M; Shimizu M; Wojcik SE; Aqeilan RI; Zupo S; Dono M; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13944-9. PubMed ID: 16166262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myb-induced chromatin remodeling at a dual enhancer/promoter element involves non-coding rna transcription and is disrupted by oncogenic mutations of v-myb.
    Wilczek C; Chayka O; Plachetka A; Klempnauer KH
    J Biol Chem; 2009 Dec; 284(51):35314-24. PubMed ID: 19841477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.
    Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; García-Serna AM; Gómez-Espuch J; Moraleda JM; Minguela A; García-Alonso AM; Parrado A
    PLoS One; 2015; 10(4):e0124936. PubMed ID: 25909590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.